HOME >> MEDICINE >> NEWS
Carcinogen in cigarettes causes mutation linked to lung cancer

l. Then they observed the effects of the chemical using their mapping technique. They found that the carcinogen preferentially bound to the K-RAS gene at a mutational hot-spot called codon 12, an area especially vulnerable to mutation. Moreover, the researchers found that this site was not able to repair itself very well. The chemical did not bind significantly to other members of the RAS gene family.

Genes comprise codons, sequences of three chemicals that spell out the code for amino acids, the building blocks of proteins. The mapping technique relies in part on special enzymes that cut DNA where it has been damaged by the binding of a carcinogen, which is technically called a DNA adduct. Adducts cause mutations in codons.

Dr. Tang says that the study's findings provide further proof that smoking does cause lung cancer because the carcinogen bound most strongly to the precise site in the K-RAS gene that is frequently mutated in lung cancer. Using the same mapping technique, he says it may be possible to discover the environmental agent or agents that are causing the gene to mutate in pancreatic cancer, which is far more commonly associated with a codon 12 mutation than is lung cancer.

"If we could identify the agents that are causing the mutations, then we might be able to design effective measures to prevent this type of cancer," says Dr. Tang.

In the future, Dr. Tang hopes to identify the mechanisms that make the codon in the K-RAS gene more susceptible to damage. He also plans to explore the possibility that there may be individual differences in susceptibility to damage at this site, meaning that some people may be more prone to certain types of cancer.

In an editorial accompanying the study in the same issue of the Journal of the National Cancer Institute, researchers Michael J. Kelley and Susan J. Littman of Duke University Medical Center, Durham, NC, write: "[U]nderstanding the bio
'"/>

Contact: Pam McDonnell
Pamela.McDonnell@med.nyu.edu
212-404-3555
New York University Medical Center and School of Medicine
15-Oct-2002


Page: 1 2 3

Related medicine news :

1. Cherry Hamburgers Lower In Suspected Carcinogens
2. Restaurant Meats Higher In Suspected Carcinogens
3. Tobacco-company-sponsored parties with free cigarettes may encourage students to start smoking
4. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
5. Activism prompts teen smokers to cut back on cigarettes, Stanford study finds
6. Heavy smokers see cigarettes as friends
7. Low tar cigarettes do not cut lung cancer risk
8. UNC study shows Internet offers youths easy way to buy cigarettes
9. Rising cost of cigarettes may help smokers honor new years resolution to quit
10. Brain chemicals can thwart desire to smoke cigarettes
11. It is easy for adolescents to purchase cigarettes illegally in North Carolina

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Carcinogen cigarettes causes mutation linked lung cancer

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: